RE104 Safety and Efficacy Study in Generalized Anxiety Disorder
NCT07489651
This study is recruiting at 27 US sites in 17 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to determine if treatment with a single and/or repeat dose of RE104 for Injection reduces anxiety symptoms in participants with Generalized Anxiety Disorder (GAD) as compared to placebo.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Generalized Anxiety Disorder
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 to 74 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Reunion Neuroscience Inc
- Last updated on ClinicalTrials.gov
- September 24, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 1
- University of Alabama (UAB) Clinical Research Unit (CRU) · Birmingham, AL
Arizona · 1
- Lighthouse Psychiatry · Gilbert, AZ
Arkansas · 1
- Preferred Research Partners, Inc. · Little Rock, AR
California · 4
- Collaborative Neuroscience Research, LLC · Garden Grove, CA
- Kadima Neuropsychiatry Institute · La Jolla, CA
- Open Mind Therapeutics · San Francisco, CA
- TRIP Clinic at Psychedelic Science Institute · Santa Monica, CA
Florida · 2
- Innovative Clinical Research, Inc. · Lauderhill, FL
- University of South Florida · Tampa, FL
Georgia · 4
- Atlanta Center for Medical Research · Atlanta, GA
- CenExel iResearch, LLC · Decatur, GA
- Evergreen Clinical Trials · Norcross, GA
- CenExel iResearch, LLC · Savannah, GA
Illinois · 1
- Uptown Research Institute · Chicago, IL
Michigan · 1
- Henry Ford Medical Center - Columbus · Novi, MI
Missouri · 1
- Midwest Research Group · Saint Charles, MO
New Mexico · 1
- UNM Research Program Psychedelic Therapies · Albuquerque, NM
New York · 1
- NYU-H+C Clinical and Translational Science Institute · New York, NY
North Carolina · 1
- University of North Carolina at Chapel Hill · Chapel Hill, NC
Ohio · 1
- Neuro-Behavioral Clinical Research, Inc. · North Canton, OH
Oregon · 1
- Summit Headlands LLC · Portland, OR
Pennsylvania · 1
- University of Pennsylvania · Philadelphia, PA
Texas · 3
- Austin Clinical Trial Partners · Austin, TX
- BioBehavioral Research Austion · Austin, TX
- Aim Trials, LLC · Plano, TX
Utah · 2
- Cedar Clinical Research · Draper, UT
- Inner Space State Street · Orem, UT
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.